Accredited & Validated Clinical Research Sequencing

Supporting clinical, translational and biopharma research with accredited WGS/WES services, validated sequencing workflows and expert project guidance.

Novogene Europe provides quality-managed sequencing services for clinical research, translational studies and biopharma programmes requiring robust genomic data and experienced project support.

Our portfolio includes ISO 17025-accredited whole genome and whole exome sequencing services, together with validated workflows for oncology research, FFPE-compatible RNA analysis and molecular profiling applications. These services are designed to support research and development projects, from rare disease and cohort studies to oncology biomarker research and retrospective tissue analysis.

Whole Genome Sequencing for Clinical Research

Our ISO 17025-accredited whole genome sequencing service supports clinical and translational research projects requiring broad genomic coverage and reliable variant analysis. By capturing both coding and non-coding regions, whole genome sequencing can support studies investigating rare disease biology, inherited conditions, complex genomic variation and cohort-level genomic research.

This service is suitable for projects where a comprehensive view of the genome is required, including analysis of SNPs, InDels, structural variants and copy number variation. Novogene Europe provides experienced project support from sample submission and quality control through to sequencing and data delivery.

View Sample Requirements

Whole Exome Sequencing for Clinical Research

Our ISO 17025-accredited whole exome sequencing service provides focused analysis of protein-coding regions, offering a practical approach for clinical research and translational genomics studies. Whole exome sequencing is widely used in rare disease research, inherited disorder studies, cohort sequencing and projects where researchers need to investigate variants in regions with known or potential biological relevance.

With quality-managed workflows and experienced technical support, this service can help researchers generate robust genomic data while maintaining a focused and cost-effective sequencing strategy.

View Sample Requirements

FFPE Exome RNA Sequencing

Our validated FFPE-compatible RNA sequencing workflow supports gene expression analysis from challenging sample types, including formalin-fixed paraffin-embedded tissue. FFPE samples are commonly used in oncology research and retrospective clinical studies, but RNA from archived tissue can be fragmented or degraded, requiring workflows designed for lower-quality input material.

This service can support translational oncology research, biomarker studies and retrospective tissue-based research where valuable archived samples need to be analysed. Novogene Europe provides project guidance to help assess sample suitability, input requirements and study design considerations.

View Sample Requirements

NovoPM 2.0 Oncology Research Panel

NovoPM 2.0 is a validated oncology research panel designed to support molecular profiling of solid tumour research samples. It focuses on cancer-related genes and genomic alterations relevant to oncology research, biomarker discovery and translational cancer studies.

This workflow can support research programmes requiring focused analysis of tumour-associated variants, including biopharma research, translational oncology studies and molecular profiling projects. It is intended for research applications and project-based sequencing support rather than direct-to-patient diagnostic testing.

Download Gene Target Table

Tell Us More About Your Next Project

Planning a clinical, translational or biopharma research study? Our team can help you review sample requirements, select the most suitable accredited or validated sequencing workflow, and support your project from initial discussion through to data delivery.